This site is intended for healthcare professionals

Vertex Pharmaceuticals applies at EMA for expanded indication of Kaftrio to treat cystic fibrosis in patients ages 12 years and older. .

Read time: 1 mins
Last updated:15th Sep 2020
Published:15th Sep 2020
Condition: Cystic Fibrosis-F508del-gene
Type: drug
Register free for full access to